These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 29096683)
1. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling. Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683 [TBL] [Abstract][Full Text] [Related]
2. The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Ariazi EA; Brailoiu E; Yerrum S; Shupp HA; Slifker MJ; Cunliffe HE; Black MA; Donato AL; Arterburn JB; Oprea TI; Prossnitz ER; Dun NJ; Jordan VC Cancer Res; 2010 Feb; 70(3):1184-94. PubMed ID: 20086172 [TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin. Chen J; Zhao X; Ye Y; Wang Y; Tian J Cell Physiol Biochem; 2013; 32(6):1790-7. PubMed ID: 24355881 [TBL] [Abstract][Full Text] [Related]
4. Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα. Wang Y; Xie W; Hou M; Tian J; Zhang X; Ren Q; Huang Y; Chen J Aging (Albany NY); 2021 Mar; 13(8):11026-11042. PubMed ID: 33647882 [TBL] [Abstract][Full Text] [Related]
5. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway. Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829 [TBL] [Abstract][Full Text] [Related]
6. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways. Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of calycosin on breast cancer cell progression through downregulating lncRNA HOTAIR and downstream targets: HuR and IGF2BP1. Li Y; Miao H; Wei W; Tian J; Chen J Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(2):225-236. PubMed ID: 36647722 [TBL] [Abstract][Full Text] [Related]
8. The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo. Wei W; Chen ZJ; Zhang KS; Yang XL; Wu YM; Chen XH; Huang HB; Liu HL; Cai SH; Du J; Wang HS Cell Death Dis; 2014 Oct; 5(10):e1428. PubMed ID: 25275589 [TBL] [Abstract][Full Text] [Related]
9. Calycosin induces apoptosis by upregulation of RASD1 in human breast cancer cells MCF-7. Tian J; Duan YX; Bei CY; Chen J Horm Metab Res; 2013 Aug; 45(8):593-8. PubMed ID: 23609007 [TBL] [Abstract][Full Text] [Related]
10. Calycosin and genistein induce apoptosis by inactivation of HOTAIR/p-Akt signaling pathway in human breast cancer MCF-7 cells. Chen J; Lin C; Yong W; Ye Y; Huang Z Cell Physiol Biochem; 2015; 35(2):722-8. PubMed ID: 25613518 [TBL] [Abstract][Full Text] [Related]
11. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. Maggiolini M; Vivacqua A; Fasanella G; Recchia AG; Sisci D; Pezzi V; Montanaro D; Musti AM; Picard D; Andò S J Biol Chem; 2004 Jun; 279(26):27008-16. PubMed ID: 15090535 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of Rab27B-dependent signaling pathway by calycosin inhibits migration and invasion of ER-negative breast cancer cells. Wu G; Niu M; Qin J; Wang Y; Tian J Gene; 2019 Aug; 709():48-55. PubMed ID: 31002890 [TBL] [Abstract][Full Text] [Related]
13. Differential ability of formononetin to stimulate proliferation of endothelial cells and breast cancer cells via a feedback loop involving MicroRNA-375, RASD1, and ERα. Chen J; Zhang X; Wang Y; Ye Y; Huang Z Mol Carcinog; 2018 Jul; 57(7):817-830. PubMed ID: 29722068 [TBL] [Abstract][Full Text] [Related]
14. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation. Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757 [TBL] [Abstract][Full Text] [Related]
15. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Sun H; Yin M; Qian W; Yin H Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951 [TBL] [Abstract][Full Text] [Related]
16. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling. Zhou K; Sun P; Zhang Y; You X; Li P; Wang T Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467 [TBL] [Abstract][Full Text] [Related]
17. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway. Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647 [TBL] [Abstract][Full Text] [Related]
18. Calycosin inhibits nasopharyngeal carcinoma cells by influencing EWSAT1 expression to regulate the TRAF6-related pathways. Kong L; Li X; Wang H; He G; Tang A Biomed Pharmacother; 2018 Oct; 106():342-348. PubMed ID: 29966979 [TBL] [Abstract][Full Text] [Related]
19. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847 [TBL] [Abstract][Full Text] [Related]
20. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways. Zhao X; Li X; Ren Q; Tian J; Chen J Gene; 2016 Oct; 591(1):123-128. PubMed ID: 27393650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]